Skip to main content

Echo Made Simple: Mastering Aortic Stenosis Assessment in One Watch

 

Echocardiographic Assessment of Aortic Stenosis (AS)

Aortic stenosis is a progressive valvular disease, and echocardiography is the cornerstone for diagnosis, grading severity, determining mechanism, and guiding timing of intervention.


1. Goals of Echocardiographic Assessment

• Confirm presence of AS

• Identify valve morphology and etiology

• Quantify severity

• Assess left ventricular (LV) response

• Detect associated lesions

• Resolve discordant or low-gradient AS



2. Valve Morphology and Etiology

2D echocardiography is used to assess:

• Number of cusps

– Tricuspid (degenerative/calcific AS)

– Bicuspid (younger patients, eccentric opening, raphe)

• Degree and distribution of calcification

• Cusp mobility and thickness

• Associated aortopathy (especially in bicuspid valve)




Parasternal short-axis view at the level of the aortic valve is key for cusp number and opening pattern.


3. Doppler Hemodynamic Assessment (Core of AS Evaluation)




A. Peak Aortic Jet Velocity (Vmax)

Measured using continuous-wave (CW) Doppler from multiple windows (apical, right parasternal, suprasternal).

Use the window with highest velocity.


Severity grading:

• Mild: 2.6–2.9 m/s

• Moderate: 3.0–3.9 m/s

• Severe: ≥4.0 m/s

• Very severe: ≥5.0 m/s


B. Mean Transvalvular Gradient

Calculated from the CW Doppler velocity-time integral (VTI).


Severity grading:

• Mild: <20 mmHg

• Moderate: 20–39 mmHg

• Severe: ≥40 mmHg


Mean gradient is preferred over peak gradient for clinical decision-making.


C. Aortic Valve Area (AVA) – Continuity Equation

AVA = (LVOT area × LVOT VTI) / Aortic VTI


LVOT area = Ο€ × (LVOT diameter/2)²

LVOT diameter is measured in parasternal long-axis during mid-systole.


Severity grading:

• Mild: >1.5 cm²

• Moderate: 1.0–1.5 cm²

• Severe: <1.0 cm²

• Indexed AVA severe: <0.6 cm²/m²


Continuity equation is flow dependent and sensitive to LVOT measurement error.


4. Dimensionless Index (Velocity Ratio)

Useful when LVOT measurement is unreliable.




Dimensionless Index = LVOT VTI / Aortic VTI


Severity grading:

• Mild: >0.50

• Moderate: 0.25–0.50

• Severe: <0.25


5. Left Ventricular Assessment




A. LV Systolic Function

• Measure LVEF

• Reduced EF suggests advanced disease or low-flow AS


B. LV Hypertrophy

• Concentric LV hypertrophy is typical

• Measure wall thickness and LV mass


C. Diastolic Function

• Diastolic dysfunction is common

• Elevated filling pressures may explain symptoms


6. Stroke Volume and Flow Status




Stroke Volume Index (SVI) = Stroke volume / BSA


Low flow is defined as:

• SVI <35 mL/m²


Flow status is essential for classifying discordant AS.


7. Classification of Severe AS Phenotypes




A. High-gradient Severe AS

• AVA <1.0 cm²

• Mean gradient ≥40 mmHg

• Vmax ≥4.0 m/s


B. Low-flow, Low-gradient Severe AS with Reduced EF

• AVA <1.0 cm²

• Mean gradient <40 mmHg

• LVEF <50%

• SVI <35 mL/m²


Dobutamine stress echo is used to:

• Differentiate true severe vs pseudo-severe AS

• Assess contractile reserve


True severe AS: AVA remains <1.0 cm² with increased gradient.


C. Paradoxical Low-flow, Low-gradient Severe AS (Preserved EF)

• AVA <1.0 cm²

• Mean gradient <40 mmHg

• LVEF ≥50%

• SVI <35 mL/m²


Often associated with:

• Small LV cavity

• Concentric remodeling

• Hypertension


8. Stress Echocardiography in AS




Indications:

• Asymptomatic severe AS

• Low-flow, low-gradient AS


Abnormal findings:

• Increase in mean gradient ≥20 mmHg

• Failure of LV contractile reserve

• Development of symptoms


9. Associated Findings to Evaluate




• Aortic regurgitation

• Mitral valve disease

• Pulmonary hypertension (TR jet velocity)

• Ascending aorta size

• LV strain (reduced GLS indicates subclinical dysfunction)


10. Common Pitfalls in Echo Assessment




• Underestimation of LVOT diameter

• Inadequate Doppler alignment

• Failure to use multiple acoustic windows

• Ignoring flow status

• Blood pressure not controlled during study


11. Reporting Checklist for AS




A complete echo report should include:

• Valve morphology and calcification

• Peak velocity, mean gradient

• AVA and indexed AVA

• Dimensionless index

• LVEF and LV geometry

• Stroke volume index

• Flow-gradient category

• Associated valvular and aortic pathology


Echocardiography remains the primary tool for comprehensive assessment of aortic stenosis, but accurate interpretation requires integration of valve hemodynamics, flow status, and ventricular response rather than reliance on a single parameter.



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.